Davenport & Co’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$713K Buy
11,137
+343
+3% +$22.5K ﹤0.01% 878
2026
Q1
$768K Sell
10,794
-870
-7% -$68.6K ﹤0.01% 791
2025
Q4
$957K Sell
11,664
-2,093
-15% -$163K 0.01% 710
2025
Q3
$1.03M Sell
13,757
-226
-2% -$16.9K 0.01% 685
2025
Q2
$1.04M Sell
13,983
-893
-6% -$62.2K 0.01% 673
2025
Q1
$1.2M Buy
14,876
+146
+1% +$12.5K 0.01% 616
2024
Q4
$1.15M Buy
14,730
+1,279
+10% +$109K 0.01% 610
2024
Q3
$1.26M Buy
13,451
+148
+1% +$12.4K 0.01% 584
2024
Q2
$1.04M Buy
13,303
+573
+5% +$46.7K 0.01% 609
2024
Q1
$1.16M Sell
12,730
-109
-0.8% -$9.07K 0.01% 584
2023
Q4
$993K Buy
12,839
+748
+6% +$52.4K 0.01% 577
2023
Q3
$823K Buy
12,091
+70
+0.6% +$5.09K 0.01% 590
2023
Q2
$977K Buy
12,021
+3,281
+38% +$262K 0.01% 564
2023
Q1
$717K Buy
+8,740
New +$624K 0.01% 627

Other funds holding GEHC

Davenport & Co's GEHC Position: Q2 2026 in Review

Davenport & Co increased its GE HealthCare (GEHC) stake by 3.2% in Q2 2026, buying an estimated $22.5K and bringing the position to 11,137 shares worth $713K. The position accounts for ﹤0.01% of the portfolio, ranked #878.

Davenport & Co first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $1.26M in Q3 2024. 209 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Davenport & Co held 11,137 shares of GE HealthCare worth $713K as of Q2 2026.
  • Davenport & Co bought 343 GE HealthCare shares in Q2 2026, an estimated $22.5K.
  • GE HealthCare made up ﹤0.01% of Davenport & Co's portfolio in Q2 2026, its #878 holding.
  • Davenport & Co first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Davenport & Co's GE HealthCare position peaked at $1.26M in Q3 2024.
  • 209 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Davenport & Co's 13F filing for Q2 2026, filed 13 Jul 2026.